Synthetic lethality: A new way to kill cancer cells
February 21, 2010 by admin · Leave a Comment
Contact: Steve Pogonowski
press@f1000.com
Faculty of 1000: Biology and Medicine
Ovarian and breast cancer treatments being developed that mix a protein inhibitor and traditional anticancer drugs are showing signs of success, according to a new review for Faculty of 1000 Biology Reports.
Single gene mutation induces endometrial cancer
February 8, 2010 by admin · Leave a Comment
Contact: Aline McKenzie
aline.mckenzie@utsouthwestern.edu
214-648-3404
UT Southwestern Medical Center
DALLAS Feb. 10, 2010 A mutation in a single gene can cause endometrial cancer that is responsive to a specific drug therapy, researchers at UT Southwestern Medical Center have found in an animal study.
A potent suppressor of endometrial cancer is revealed
February 7, 2010 by admin · Leave a Comment
Contact: Kristy Kain
kristy.kain@vanderbilt.edu
615-343-1298
The Company of Biologists Read more
Disarming specialized stem cells might combat deadly ovarian cancer
January 26, 2010 by admin · Leave a Comment
Contact: Karen N. Peart
karen.peart@yale.edu
203-432-1326
Yale University
Eliminating cancer stem cells (CSCs) within a tumor could hold the key to successful treatments for ovarian cancer, which has been notoriously difficult to detect and treat, according to new findings published this week in the journal Oncogene by Yale School of Medicine researchers.
Cervical cancer: Combined drug and radiotherapy improves survival
January 18, 2010 by admin · Leave a Comment
Contact: Jennifer Beal
medicalnews@wiley.com
44-012-437-70633
Wiley-Blackwell
Combining drugs and radiotherapy improves the survival chances of women receiving treatment for cervical cancer. These are the conclusions of Cochrane Researchers who carried out the most comprehensive study of the effects of combined drug and radiotherapy in cervical cancer treatment to date.
‘Junk DNA’ could spotlight breast and bowel cancer
January 4, 2010 by admin · Leave a Comment
Contact: Simon Shears
simon.shears@cancer.org.uk
44-207-061-8054
University of Nottingham
Scientists at The University of Nottingham have found that a group of genetic rogue elements, produced by DNA sequences commonly known as ‘junk DNA’, could help diagnose breast and bowel cancer. Their research, funded by Cancer Research UK, is published in this month’s Genomics journal.
Research suggests link between infertility, low egg reserve, and breast/ovarian cancer gene (BRCA1)
December 17, 2009 by admin · Leave a Comment
Contact: Donna E. Moriarty, M.P.H.
donna_moriarty@nymc.edu
914-594-4536
New York Medical College Read more
Possible ovarian cancer treatment target identified
December 7, 2009 by admin · Leave a Comment
Contact: Sue McGreevey
smcgreevey@partners.org
617-724-2764
Massachusetts General Hospital Read more
FDA-approved breast cancer and osteoporosis drugs eliminate, prevent cervical cancer in mice
November 9, 2009 by admin · Leave a Comment
Researchers at the University of Wisconsin-Madison School of Medicine and Public Health have eliminated cervical cancer in mice with two FDA-approved drugs currently used to treat breast cancer and osteoporosis.
Metals could forge new cancer treatment against colon and ovarian cancer
October 19, 2009 by admin · Leave a Comment
Drugs made using unusual metals could form an effective treatment against colon and ovarian cancer, including cancerous cells that have developed immunity to other drugs, according to research at the University of Warwick and the University of Leeds.
